Issued 2026-09-16 at $4.39 · now $4.39 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, UROY has typically landed between $3.37 and $5.84 — a range of −23.3% to +33.0% from the issuance price $4.39.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,655 overlapping 1 month windows · 2020-01-14 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($4.39) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where UROY has typically landed a month from the 2026-09-16 close of $4.39 — the range is history, not a prediction.
- now $4.39 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $4.35 (-0.8%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $3.83–$4.88
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.37–$5.84
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2022-04-12 | −42.8% | −42.8% | +1.4% |
| 2022-04-11 | −41.5% | −41.5% | +0.0% |
| 2022-04-13 | −37.5% | −43.5% | +0.0% |
| 3 best | |||
| 2021-08-16 | +120.0% | −4.1% | +120.0% |
| 2021-08-17 | +112.8% | −6.0% | +115.6% |
| 2021-01-19 | +86.4% | +0.0% | +86.4% |
1,655 overlapping windows · 2020-01-14 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~7 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-30 | MELBYE SCOTT | director | Purchase | 5,850 @ $3.13 | $18K | +1.0% of holding | +20.8% | not yet — horizon still open | 615,898 | Form 4 · filed same day |
| 2026-07-30 | MELBYE SCOTT | director | Purchase | 4,000 @ $3.13 | $13K | +0.7% of holding | +20.8% | not yet — horizon still open | 610,048 | Form 4 · filed same day |
| 2026-07-30 | MELBYE SCOTT | director | Purchase | 4,000 @ $3.12 | $12K | +0.7% of holding | +20.8% | not yet — horizon still open | 606,048 | Form 4 · filed same day |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.